Question about Williams Design [Design Issues]

posted by Bebac user – Egypt, 2025-02-25 21:30 (130 d 15:42 ago) – Posting: # 24376
Views: 1,448

Hello Dears,

Is this study design acceptable?

## Williams design ##

Three treatments, three phases and six sequences.

T1.. Metformin 1000 XR, sitagliptin 100mg and Empagliflozin 25mg.
T2.. Sitagliptin 100mg and Empagliflozin 25mg.
R1.. Metformin 1000 XR, sitagliptin 100mg and Empagliflozin 25mg.

Thanks in advance.

Complete thread:

UA Flag
Activity
 Admin contact
23,427 posts in 4,929 threads, 1,676 registered users;
43 visitors (0 registered, 43 guests [including 13 identified bots]).
Forum time: 14:12 CEST (Europe/Vienna)

Many people tend to look at programming styles and languages like religions:
if you belong to one, you cannot belong to others.
But this analogy is another fallacy.    Niklaus Wirth

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5